
LN Future Investor Relations Material
Latest events

H1 2025
29 Aug, 2025

H2 2024
28 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from LN Future AB
Access all reports
Ellen AB is a Sweden-based biotechnology company specializing in probiotic sanitary protection products for women. The company's primary product is the Ellen tampon, which is designed to support vaginal health using patented lacto acid bacteria, known as Lacto Naturel (LN). This product is made from natural fibers infused with LN, a substance derived from human lactic acid bacteria that helps maintain a healthy vaginal environment and provides protection against infections. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
LNFI
Country
🇸🇪 Sweden